TruAlt Bioenergy Limited has informed the Exchange about Investor Presentation
TRUALT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
TruAlt Bioenergy reported a challenging FY2025-26 with standalone total income declining 8.64% to ₹1,772.94 crore due to sharp cuts in ethanol lifting by Oil Marketing Companies (OMCs) despite fully operational capacities. Q4 standalone revenue fell 32.46% quarter-on-quarter to ₹616.62 crore. Standalone PAT dropped 43.09% to ₹80.03 crore for the full year. The company highlighted a pending ~15 crore litre ethanol allocation backed by Karnataka High Court, representing estimated revenue potential of ₹1,062 crore. The ethanol segment saw 11.33% revenue decline, while CBG emerged as a bright spot with 185% PAT growth to ₹18.06 crore. The company transitioned ~1,300 KLPD of its 2,000 KLPD ethanol capacity to dual-feed operations for near year-round production.
Shareholders face near-term earnings pressure from reduced OMC ethanol allocations and competitive retail fuel margins, though the pending ₹1,062 crore court order and growing CBG contribution provide recovery potential. The strategic shift to multi-feed ethanol and expansion into SAF represent long-term value drivers amid India's energy transition push.